BRUSSELS The European Medicines Agency's (EMA) human medicines committee on Friday recommended the approval of a combined coronavirus and seasonal influenza vaccine developed by Moderna for adults aged 50 and over. The vaccine, known as mCombriax, is the first mRNA‑based combination vaccine to receive a positive opinion from European regulators, according to a statement. Clinical data showed that recipients of the combined vaccine generated immune responses comparable to those who received

Tag-uri: Coronavirus